Cosmo Pharmaceuticals NV (CMOPF)

152.00 -6.04 (-3.82%) USD  |  OTCM  |  Feb 23, 16:00
More

Cosmo Pharmaceuticals Net Change in Capital Expenditures (Quarterly)

Net Change in Capital Expenditures (Quarterly) Chart

View Net Change in Capital Expenditures (Quarterly) for CMOPF.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Net Change in Capital Expenditures (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Net Change in Capital Expenditures (Quarterly) Range, Past 5 Years

View Net Change in Capital Expenditures (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Net Change in Capital Expenditures (Quarterly) Benchmarks

View Net Change in Capital Expenditures (Quarterly) Benchmarks
Start Trial
Amarin Corp. Plc Upgrade
Jazz Pharmaceuticals Plc Upgrade
Prothena Corp. Plc --
Iterum Therapeutics Plc Upgrade
GH Research Plc Upgrade